Citius Pharmaceuticals, Inc.
CTXR
Revenue
0.00
0.000.00%
3 Months ChangeAssets
97.09M
▲6.38M▲7.03%
3 Months ChangeLiabilities
10.81M
▲61.88k▲0.5759%
3 Months ChangeFree Cash Flow
-24.26M
▼-7.32M▼-43.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001213900-24-082809
2024-09-13
Form 8-K
ID: 0001213900-24-078288
2024-09-11
Form 8-K
ID: 0001213900-24-077777
2024-09-05
Form 8-K
ID: 0001213900-24-076108
2024-08-16
Form 8-K
ID: 0001213900-24-070285
2024-08-12
Form 8-K
ID: 0001213900-24-067778
2024-08-12
Form 10-Q
ID: 0001213900-24-067732
2024-08-08
Form 8-K
ID: 0001213900-24-066357
2024-05-21
Form 8-K
ID: 0001213900-24-045573
2024-05-14
Form 8-K
ID: 0001213900-24-042966